Autres langues Avid Bioservices, Inc.

Actions

CDMO

US05368M1062

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
7,67 ^USD	+0,52 %		+12,30 %	+18,00 %

30/04	AVID BIOSERVICES, INC. : RBC Capital Markets toujours à l'achat	ZM
29/04	Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avid Bioservices: Fiscal Q3 Earnings Snapshot	24/04
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024	24/04
Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	24/04
North American Morning Briefing : Stock Futures -2-	19/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	12/04
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	05/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	05/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO	27/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Avid Bioservices Receives Nasdaq Noncompliance Notice	20/03
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q	20/03
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	15/03
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	14/03
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	14/03
Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	14/03
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors	13/03
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	08/03
Avid Bioservices Prices $160 Million Convertible Notes Offering; Shares Slump	07/03
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO	07/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Buoyed by Powell's Comments	07/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Avid Bioservices, Inc.

Actions

CDMO

US05368M1062

Autres langues

Filtres